Search Results

Atorvastatin-induced intracerebral hemorrhage is inhibited by berberine in zebrafish.

• Authors : Liu XY; Key Laboratory of Biotechnology of Antibiotics, the National Health Commission (NHC), Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Chen B

Subjects: Zebrafish* ; Atorvastatin*/Atorvastatin*/Atorvastatin*/pharmacology ; Cerebral Hemorrhage*/Cerebral Hemorrhage*/Cerebral Hemorrhage*/chemically induced

• Source: Journal of applied toxicology : JAT [J Appl Toxicol] 2024 Aug; Vol. 44 (8), pp. 1198-1213. Date of Electronic Publication: 2024 Apr 19.Publisher: John Wiley And Sons Country of Publication: England NLM ID: 8109495 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Establishment and validation of a CT-based prediction model for the good dissolution of mild chronic subdural hematoma with atorvastatin treatment.

• Authors : Zhang X; Department of Neurosurgery, Tianjin Medical University General Hospital, Anshan Road 154, Heping District, Tianjin, 300070, China.; Department of Pediatric Neurosurgery, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.

Subjects: Atorvastatin*/Atorvastatin*/Atorvastatin*/therapeutic use ; Hematoma, Subdural, Chronic*/Hematoma, Subdural, Chronic*/Hematoma, Subdural, Chronic*/diagnostic imaging ; Hematoma, Subdural, Chronic*/Hematoma, Subdural, Chronic*/Hematoma, Subdural, Chronic*/drug therapy

• Source: Neuroradiology [Neuroradiology] 2024 Jul; Vol. 66 (7), pp. 1113-1122. Date of Electronic Publication: 2024 Apr 08.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 1302751 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Expression of Concern: Atorvastatin ameliorates early brain injury through inhibition of apoptosis and ER stress in a rat model of subarachnoid hemorrhage.

Subjects: Subarachnoid Hemorrhage*/Subarachnoid Hemorrhage*/Subarachnoid Hemorrhage*/drug therapy ; Subarachnoid Hemorrhage*/Subarachnoid Hemorrhage*/Subarachnoid Hemorrhage*/metabolism ; Subarachnoid Hemorrhage*/Subarachnoid Hemorrhage*/Subarachnoid Hemorrhage*/pathology

• Source: Bioscience reports [Biosci Rep] 2024 Aug 28; Vol. 44 (8).Publisher: Portland Press on behalf of the Biochemical Society Country of Publication: England NLM ID: 8102797 Publication Model: Print Cited Medium:

Record details

3D printed scaffolds as delivery devices for nanocrystals: A proof of concept loading Atorvastatin with enhanced properties for sublingual route of administration.

• Authors : Barrientos BA; Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA), CONICET, Argentina; Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Haya de la Torre y Medina Allende, X5000XHUA Córdoba, Argentina.

Subjects: Atorvastatin*/Atorvastatin*/Atorvastatin*/administration & dosage ; Atorvastatin*/Atorvastatin*/Atorvastatin*/chemistry ; Nanoparticles*/Nanoparticles*/Nanoparticles*/chemistry

• Source: International journal of pharmaceutics [Int J Pharm] 2024 Aug 15; Vol. 661, pp. 124396. Date of Electronic Publication: 2024 Jun 27.Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium:

Record details

Evaluation of the effect of atorvastatin on corneal endothelial cells during the initial 12-month period after acute coronary syndrome.

• Authors : Karapapak M; Department of Ophthalmology, Başakşehir Çam and Sakura City Hospital, Turkey.; Demirtola İ

Subjects: Atorvastatin*/Atorvastatin*/Atorvastatin*/therapeutic use ; Endothelium, Corneal*/Endothelium, Corneal*/Endothelium, Corneal*/pathology ; Endothelium, Corneal*/Endothelium, Corneal*/Endothelium, Corneal*/drug effects

• Source: Indian journal of ophthalmology [Indian J Ophthalmol] 2024 Aug 01; Vol. 72 (8), pp. 1142-1146. Date of Electronic Publication: 2024 Jul 29.Publisher: Medknow Publications Country of Publication: India NLM ID: 0405376 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Inhibition of mevalonate pathway by macrophage-specific delivery of atorvastatin prevents their pro-inflammatory polarisation.

• Authors : Krejčová G; Faculty of Science, Department of Molecular Biology and Genetics, University of South Bohemia, České Budějovice, Czech Republic.; Biology Centre CAS, Institute of Entomology, České Budějovice, Czech Republic.

Subjects: Atorvastatin*/Atorvastatin*/Atorvastatin*/pharmacology ; Atorvastatin*/Atorvastatin*/Atorvastatin*/administration & dosage ; Macrophages*/Macrophages*/Macrophages*/metabolism

• Source: Insect molecular biology [Insect Mol Biol] 2024 Aug; Vol. 33 (4), pp. 323-337. Date of Electronic Publication: 2024 Feb 17.Publisher: Blackwell Scientific For The Royal Entomological Society Country of Publication: England NLM ID: 9303579 Publication Model: Print-Electronic

Record details

Validation of a novel direct method to determine reduced adherence to atorvastatin therapy.

• Authors : Pivoriunas J; Department of Medicine, Drammen Hospital, Vestre Viken Hospital Trust, Postboks 800, Drammen 3004, Norway.; Department of Behavioural Medicine, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Domus Medica, Sognsvannsveien 9, Oslo 0372, Norway.

Subjects: Atorvastatin*/Atorvastatin*/Atorvastatin*/pharmacokinetics ; Atorvastatin*/Atorvastatin*/Atorvastatin*/therapeutic use ; Atorvastatin*/Atorvastatin*/Atorvastatin*/blood

• Source: European heart journal. Cardiovascular pharmacotherapy [Eur Heart J Cardiovasc Pharmacother] 2024 Jul 16; Vol. 10 (4), pp. 307-315.Publisher: Oxford University Press Country of Publication: England NLM ID: 101669491 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Optimization of atorvastatin and quercetin-loaded solid lipid nanoparticles using Box-Behnken design.

• Authors : Lalchandani DS; Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education & Research-Guwahati (NIPER-G), Changsari, Guwahati, Assam 781101, India.; Chenkual L

Subjects: Atorvastatin*/Atorvastatin*/Atorvastatin*/chemistry ; Atorvastatin*/Atorvastatin*/Atorvastatin*/pharmacology ; Atorvastatin*/Atorvastatin*/Atorvastatin*/administration & dosage

• Source: Nanomedicine (London, England) [Nanomedicine (Lond)] 2024 Jul 14; Vol. 19 (17), pp. 1541-1555. Date of Electronic Publication: 2024 Jul 16.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101278111 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

PKMYT1 knockdown inhibits cholesterol biosynthesis and promotes the drug sensitivity of triple-negative breast cancer cells to atorvastatin.

• Authors : Gao W; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.; Guo X

Subjects: Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/genetics ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/pathology

• Source: PeerJ [PeerJ] 2024 Jul 12; Vol. 12, pp. e17749. Date of Electronic Publication: 2024 Jul 12 (Print Publication: 2024).Publisher: PeerJ Inc Country of Publication: United States NLM ID: 101603425 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial.

• Authors : Lee JE; Division of Endocrinology and Metabolism, Department of Internal Medicine, Uijeongbu Eulji Medical Center, Eulji University School of Medicine, Uijeongbu, Korea.; Yu SH

Subjects: Atorvastatin*/Atorvastatin*/Atorvastatin*/therapeutic use ; Atorvastatin*/Atorvastatin*/Atorvastatin*/administration & dosage ; Metformin*/Metformin*/Metformin*/therapeutic use

• Source: Diabetes & metabolism journal [Diabetes Metab J] 2024 Jul; Vol. 48 (4), pp. 730-739. Date of Electronic Publication: 2024 May 20.Publisher: Korean Diabetes Association Country of Publication: Korea (South) NLM ID: 101556588 Publication Model: Print-Electronic Cited Medium:

Record details